Skip to content
value.today

Celtaxsys, Inc.

🇺🇸 Atlanta, Georgia, USABiotechnologyFounded 2007
Total raised
$26 M
2 rounds on record
Latest round
$22 M
Jun 2015
First round on record
Oct 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Celtaxsys, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2015$22 MNo. 2$10 to $50 million

Celtaxsys, Inc.: Raise no. 2, Jun 2015

Investors in this round

8 investors had bought by the notice of Jun 17, 2015: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $40 M offered; $18 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,000,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric Daniel Springman · Executive Officer
  • Greg Duncan · Executive Officer, Director
  • Sanjeev P. Ahuja, M.D. · Executive Officer
  • William P. Reddick · Executive Officer
  • Gerry Daniel Brunk · Director
  • H. Daniel Perez, M.D. · Director
  • Maxim Daniel Gorbachev · Director
  • Michael W. Masters · Director
  • Nicole P. Vitullo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Livingston Securities, LLC (CRD 147364) · broker-dealer Livingston Securities, LLC (CRD 147364) · New York, New YorkSold in GA, NJ

Signed by William P. Reddick, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 17, 2015. Read the notice at the SEC.

equitySEC
Oct 2010$4 MNo. 1$2 to $10 million

Celtaxsys, Inc.: Raise no. 1, Oct 2010

Investors in this round

6 investors had bought by the notice of Oct 29, 2010: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $11 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric S. Springman · Executive Officer
  • Michael A. Hanley · Executive Officer, Director
  • Ralph A. Grosswald · Executive Officer
  • William P. Reddick · Executive Officer, Director
  • Jan M. Lodal · Director
  • Matthew S. Dontzin · Director
  • Michael W. Masters · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William P. Reddick, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 29, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Celtaxsys, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2015).

    SEC Form D · Jun 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2015

That is all the official record says: Celtaxsys, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Celtaxsys, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 8 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Celtaxsys, Inc.
NameRoleNamed in
Eric Daniel SpringmanExecutive officerJun 2015
Greg DuncanExecutive officerJun 2015
Sanjeev P. Ahuja, M.D.Executive officerJun 2015
William P. ReddickExecutive officerJun 2015
Eric S. SpringmanExecutive officerOct 2010
Michael A. HanleyExecutive officerOct 2010
Ralph A. GrosswaldExecutive officerOct 2010
Gerry Daniel BrunkDirectorJun 2015
Greg DuncanDirectorJun 2015
H. Daniel Perez, M.D.DirectorJun 2015
Maxim Daniel GorbachevDirectorJun 2015
Michael W. MastersDirectorJun 2015
Nicole P. VitulloDirectorJun 2015
Jan M. LodalDirectorOct 2010
Matthew S. DontzinDirectorOct 2010
Michael A. HanleyDirectorOct 2010
William P. ReddickDirectorOct 2010